Tetralogic Pharmaceuticals Corp Stock Nasdaq
Equities
US88165U1097
Biotechnology & Medical Research
Financials (USD)
Sales 2014 | - | Sales 2015 | - | Capitalization | 42.07M |
---|---|---|---|---|---|
Net income 2014 | -36M | Net income 2015 | -49M | EV / Sales 2014 | - |
Net cash position 2014 | 22.32M | Net Debt 2015 | 7.92M | EV / Sales 2015 | - |
P/E ratio 2014 |
-2.96
x | P/E ratio 2015 |
-0.82
x | Employees | - |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
Managers | Title | Age | Since |
---|---|---|---|
President | - | - | |
Treasurer | 66 | 14-01-31 | |
Dick L. Sherman
SEC | Corporate Secretary | 76 | 12-10-31 |
1st Jan change | Capi. | |
---|---|---|
-3.39% | 102B | |
+2.61% | 96.84B | |
-0.96% | 21.48B | |
-18.14% | 20.82B | |
-7.29% | 18.6B | |
-40.70% | 16.81B | |
-26.89% | 13.78B | |
+1.12% | 13.4B | |
+22.25% | 11.06B |